Hodgkin Lymphoma: Intensifying Treatment With Rituximab After PET
Adjusting treatment dose after 2 courses of first-line therapy based on a positive PET scan does not improve progression-free survival.
Diagnosis & Disease Information
Hodgkin Lymphoma Survivors Treated With Anthracyclines Have 3-fold Risk of Heart Failure
Treatment with anthracyclines increases the risk for developing heart failure by 3-fold independently of radiation dose among survivors of Hodgkin lymphoma.
Coping With Waldenstrom Macro-globulinemia
A diagnosis of Waldenstrom’s Macroglobulinemia can leave you and your loved ones feeling uncertain, anxious and overwhelmed.
Bendamustine, Gemcitabine, Vinorelbine Promising Treatment for Relapsed or Refractory Hodgkin Lymphoma
BeGEV appears to provide clinical benefit for patients with relapsed or refractory Hodgkin lymphoma, and ought to be developed further.
Early MRI-based Screening May Reduce Breast Cancer Mortality Among Lymphoma Survivors
Early MRI-based screening may reduce breast cancer mortality among women treated with radiotherapy (RT) for childhood Hodgkin lymphoma.
UV Light Exposure May Be Inversely Associated With Hodgkin Lymphoma
Hodgkin lymphoma incidence was lower in areas of the United States with more ultraviolet radiation exposure.
PET Response-adapted Therapy in Advanced-stage Hodgkin Lymphoma Appears Beneficial
Patients with advanced-stage Hodgkin lymphoma who were at high risk for treatment failure as determined by interim PET response.
VEPEMB Compared With ABVD for Older Patients With Hodgkin Lymphoma
Standard ABVD was associated with a significant improvement in survival in older patients with Hodgkin lymphoma.
Treatment Disparity Identified in HIV-positive Black Patients With Hodgkin Lymphoma
Significant disparities have been found in HIV-positive black patients with Hodgkin lymphoma, with regard to both rate of diagnosis and chemotherapy usage.
ABVD Shows Higher Progression-free Survival in Hodgkin Lymphoma
Patients with advanced Hodgkin lymphoma treated with BEACOPP or CEC did not show a progression-free survival.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...